Study of Hepatoma Treated by Perfusing Cinobufacin Through Hepatic Artery Combining Embolotherapy
Status:
Unknown status
Trial end date:
2013-11-01
Target enrollment:
Participant gender:
Summary
Cinobufacini has the effects of anticancer, improving the liver function, elevation of
immunity and little side effects, and is important and significant for the patients with
hepatitis, liver cirrhosis and hepatomas.
Compared with transarterial chemoembolization (TACE) , the clinical effect of cinobufacini is
non-inferior/ equivalent.Compared with TACE, cinobufacini is superior in security .